Tian Xu, Zhang Jian, Yan Liang, Dong Jing-Ming, Guo Qiang
Department of Traumatology, Tianjin Hospital Tianjin 300211, PR China.
Department of Traumatology, Tianjin Baodi Hospital Tianjin 301800, PR China.
Int J Clin Exp Pathol. 2015 Jun 1;8(6):6442-9. eCollection 2015.
Recent data strongly suggest the important role of miRNAs in various cancer-related processes. Osteosarcoma is the most common type of primary malignant bone tumor and is characterized by complex genetic changes and resistance to conventional treatments. In this study, the role of miRNA-15a (miR-15a) in the progression and metastasis of osteosarcoma was investigated. The result demonstrated that the expression of miR-15a was down-regulated in osteosarcoma tissues and cell lines as compared with that in adjacent non-neoplastic bone tissues and the osteoblastic cell line. In functional assays, miR-15a inhibited cell proliferation, migration and invasion in U2OS and MG-63 cells. Meanwhile, bioinformatic analysis combined with experimental confirmation demonstrated that tumor necrosis factor; α-induced protein 1 (TNFAIP1) gene is a potential target of miR-15a and can be directly regulated by miR-15a. Down-regulation of TNFAIP1 induced effects on osteosarcoma cell lines similar to those induced by miR-15a. Taken together, these data suggest that miR-15a may act as a tumor suppressor, which is commonly down-regulated in both osteosarcoma tissues and cells. TNFAIP1 plays an important role in mediating miR-15a dependent biological functions in osteosarcoma. Reintroduction of miR-15a may be a novel therapeutic strategy by down-regulating TNFAIP1 expression.
近期数据有力地表明了微小RNA(miRNA)在各种癌症相关过程中的重要作用。骨肉瘤是原发性恶性骨肿瘤最常见的类型,其特征为复杂的基因变化以及对传统治疗的耐药性。在本研究中,对miRNA - 15a(miR - 15a)在骨肉瘤进展和转移中的作用进行了研究。结果表明,与相邻的非肿瘤性骨组织和成骨细胞系相比,miR - 15a在骨肉瘤组织和细胞系中的表达下调。在功能试验中,miR - 15a抑制了U2OS和MG - 63细胞的增殖、迁移和侵袭。同时,生物信息学分析结合实验证实肿瘤坏死因子α诱导蛋白1(TNFAIP1)基因是miR - 15a的潜在靶标,且可被miR - 15a直接调控。TNFAIP1的下调对骨肉瘤细胞系产生的影响类似于miR - 15a诱导的影响。综上所述,这些数据表明miR - 15a可能作为一种肿瘤抑制因子,在骨肉瘤组织和细胞中通常下调。TNFAIP1在介导miR - 15a在骨肉瘤中的依赖生物学功能方面发挥重要作用。重新引入miR - 15a可能是一种通过下调TNFAIP1表达的新型治疗策略。